453P Routine DPYD mutation testing for patients receiving fluoropyrimidines for gastrointestinal (GI) cancers: Real world experience in a tertiary UK oncology centre

Autor:	C. Fong, D.K.W. Lau, M.B. Razzaq, H. Katifi, F. Arouri, David Cunningham, Charlotte Fribbens, Ian Chau, Naureen Starling, Sheela Rao, A. Macklin-Doherty, L. Cortez, D. Watkins, Reyes Gonzalez-Exposito, S. Li
Rok vydání:	2021
Předmět:	Oncology medicine.medical_specialty business.industry Internal medicine Mutation testing Medicine DPYD Hematology business
Zdroj:	Annals of Oncology. 32:S559
ISSN:	0923-7534
DOI:	10.1016/j.annonc.2021.08.974
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e53025fa60f0363c4013d2e912f56e73 https://doi.org/10.1016/j.annonc.2021.08.974 Zobrazit plný text záznamu